Publications by authors named "Gerald Post"

Claim this Profile
R
Real-world evidence couples genomic biomarkers with therapeutic outcomes for canine hemangiosarcoma.
Lucas Rodrigues, Kevin Wu, Garrett Harvey, Gerald Post, Aubrey Miller

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Medicine in Veterinary Science.
Esther Chon, William Hendricks, Michelle White, Lucas Rodrigues, David Haworth, Gerald Post

Vet Clin North Am Small Anim Pract· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a high-protein, increased-fibre, dry diet supplemented with omega-3 fatty acids on quality of life in dogs undergoing chemotherapy.
Cailin R Heinze, Kristine E Burgess, Lisa G Barber, Kenneth M Rassnick, Gerald S Post

Vet Comp Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma.
Timothy Estabrooks, Anastasia Gurinovich, Jodie Pietruska, Benjamin Lewis, Garrett Harvey, Gerald Post

Vet Comp Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared hotspot mutations in oncogenes position dogs as an unparalleled comparative model for precision therapeutics.
Lucas Rodrigues, Joshua Watson, Yuan Feng, Benjamin Lewis, Garrett Harvey, Gerald Post

Sci Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs.
Kevin Wu, Lucas Rodrigues, Gerald Post, Garrett Harvey, Michelle White

NPJ Precis Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: A Double-Blinded Study.
Gerald S Post, Jonathan Lustgarten

Top Companion Anim Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, randomized, double-blinded, placebo-controlled study of rabacfosadine in dogs with lymphoma.
Kristen M Weishaar, Zachary M Wright, Mona P Rosenberg, Gerald S Post, Jennifer A McDaniel

J Vet Intern Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancer.
Hester A Doyle, Renelle J Gee, Tyler D Masters, Christian R Gee, Carmen J Booth, Gerald R Post

Transl Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials.
Corey F Saba, Craig Clifford, Kristine Burgess, Brenda Phillips, David Vail, Gerald Post

Vet Comp Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs.
Jacob R Cawley, Zachary M Wright, Karri Meleo, Gerald S Post, Craig A Clifford

J Vet Intern Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis.
William P D Hendricks, Victoria Zismann, Karthigayini Sivaprakasam, Christophe Legendre, Kelsey Poorman, Gerald Post

PLoS Genet· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional responders in conservation.
Gerald Post, Jonas Geldmann

Conserv Biol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective evaluation of toceranib phosphate (Palladia) use in cats with mast cell neoplasia.
Erika P Berger, Chad M Johannes, Gerald S Post, Gillian Rothchild, Kai-Biu Shiu

J Feline Med Surg· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of toceranib phosphate (Palladia) when used in conjunction with other therapies in 35 cats with feline oral squamous cell carcinoma: 2009-2013.
Gina A Olmsted, John Farrelly, Gerald S Post, Jaclyn Smith

J Feline Med Surg· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells.
Cheryl A London, Heather L Gardner, Sarah Rippy, Gerald Post, Krista La Perle

Clin Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
Cheryl A London, Heather L Gardner, Tamra Mathie, Nicole Stingle, Roberta Portela, Gerald Post

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses.
Nicholas J Roberts, Linping Zhang, Filip Janku, Amanda Collins, Ren-Yuan Bai, Gerald Post

Sci Transl Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrophilic agarose macrobead cultures select for outgrowth of carcinoma cell populations that can restrict tumor growth.
Barry H Smith, Lawrence S Gazda, Bryan L Conn, Kanti Jain, Shirin Asina, Gerald S Post

Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I clinical trial evaluating imatinib mesylate (Gleevec) in tumor-bearing cats.
Joshua L Lachowicz, Gerald S Post, Edwin Brodsky

J Vet Intern Med· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.
Cheryl A London, Alison L Hannah, Regina Zadovoskaya, May B Chien, Cynthia Kollias-Baker, Gerald Post

Clin Cancer Res· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Water transport in the kidney and nephrogenic diabetes insipidus.
Michele Cohen, Gerald S Post

J Vet Intern Med· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal leiomyosarcoma in 14 dogs.
Michele Cohen, Gerald S Post, James C Wright

J Vet Intern Med· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis